Millennium Management’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $675K | Sell |
159,524
-1,228,325
| -89% | -$5.5M | ﹤0.01% | 4621 |
|
|
2025
Q4 | $5.23M | Buy |
1,387,849
+1,073,147
| +341% | +$2.09M | ﹤0.01% | 2953 |
|
|
2025
Q3 | $507K | Sell |
314,702
-812,523
| -72% | -$1.45M | ﹤0.01% | 5063 |
|
|
2025
Q2 | $2.47M | Buy |
+1,127,225
| New | +$1.73M | ﹤0.01% | 3692 |
|
|
2024
Q4 | – | Sell |
-46,335
| Closed | -$57.9K | – | 6561 |
|
|
2024
Q3 | $57.9K | Sell |
46,335
-104,113
| -69% | -$127K | ﹤0.01% | 5669 |
|
|
2024
Q2 | $179K | Buy |
+150,448
| New | +$205K | ﹤0.01% | 5181 |
|
|
2024
Q1 | – | Sell |
-11,239
| Closed | -$11.9K | – | 6750 |
|
|
2023
Q4 | $11.9K | Buy |
+11,239
| New | +$12.2K | ﹤0.01% | 5715 |
|
|
2023
Q1 | – | Sell |
-61,179
| Closed | -$144K | – | 6942 |
|
|
2022
Q4 | $144K | Buy |
61,179
+36,396
| +147% | +$102K | ﹤0.01% | 5457 |
|
|
2022
Q3 | $50K | Buy |
+24,783
| New | +$68.4K | ﹤0.01% | 6186 |
|
|
2021
Q4 | – | Sell |
-12,161
| Closed | -$111K | – | 7409 |
|
|
2021
Q3 | $111K | Buy |
+12,161
| New | +$113K | ﹤0.01% | 6391 |
|
|
2019
Q3 | – | Sell |
-423
| Closed | -$2K | – | 4525 |
|
|
2019
Q2 | $2K | Buy |
+423
| New | +$15K | ﹤0.01% | 3989 |
|
|
2017
Q4 | – | Sell |
-45
| Closed | -$24K | – | 4056 |
|
|
2017
Q3 | $24K | Sell |
45
-30
| -40% | -$19.8K | ﹤0.01% | 3441 |
|
|
2017
Q2 | $65K | Sell |
75
-131
| -64% | -$114K | ﹤0.01% | 3344 |
|
|
2017
Q1 | $188K | Sell |
206
-6
| -3% | -$9.94K | ﹤0.01% | 3224 |
|
|
2016
Q4 | $618K | Buy |
+212
| New | +$1.23M | ﹤0.01% | 2557 |
|
Other funds holding SLS
VCM
VPM
VFT